🚀 Cellino is excited to sponsor the ISSCR Copenhagen International Symposium (#ISSCR2024) from 2-4 October 2024! This International Society for Stem Cell Research gathering is a unique opportunity to deep dive into the latest advancements in PSC-derived cell therapies, clinical advances, and next generation technologies that are revolutionizing personalized regenerative medicine. 🔬We’re proud to have our leadership team joining the event: Nabiha Saklayen, CEO & Co-Founder Marinna Madrid, PhD, Chief Product Officer & Co-Founder Rebecca "Becky" Kusko, PhD, Head of Corporate Strategy and Affairs Join us in #Copenhagen to discover how these innovations are shaping the future of personalized medicines. Let’s connect to discuss the latest in stem cell research, clinical translation, and the regulatory challenges and opportunities ahead. 🌐 🤝 📅 Save the date: 2-4 October 2024 📍 Copenhagen, Denmark 🔗 Learn more and register: https://bit.ly/49Hvcvh #CellinoBio #StemLeaders #Biotech #BiotechInnovation #Collaboration #Therapeutics #ResearchAndDevelopment #PersonalizedMedicine #RegenMed #YourCellsYourCure #Conference #ISSCR
Cellino
Biotechnology Research
Cambridge, Massachusetts 15,450 followers
Your Cells, Your Cure™
About us
Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies. Cellino’s vision is to enable healthier lives worldwide with personalized treatments derived from induced pluripotent stem cells (iPSCs), which can serve as the basis for therapies for a host of chronic degenerative diseases, including vision loss and Parkinson's disease.
- Website
-
http://www.cellinobio.com
External link for Cellino
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
750 Main Street
Cambridge, Massachusetts 02139, US
Employees at Cellino
Updates
-
🚀 Cellino is excited to join the conversation at LSX World Congress USA next week in #Boston! Hear from our CEO & Co-Founder, Nabiha Saklayen, on Day 2 (Sept. 12) from 10:00 to 10:30 AM EDT as she discusses "Startup Success: Securing an $80M Series A to Scale Regeneration Tech" with moderator Anula Jayasuriya, Co-Founder of Kidron Capital Assets LP. This session explores the steps and strategies behind building a successful #biotech startup and achieving significant milestones. If you’re attending the event, be sure to also mark your calendars for 11:00 AM EDT, when our Head of Public Engagement, Willie T. Reaves, will speak on the panel "Healthtech is Not Donkeys & Elephants: Making Healthcare Fairer & More Equitable Across the Nation." 🗓️ Learn more and see the full schedule at www.lsxleaders.com/USA #LSXUSA #Healthtech #Biotechnology #AI #MachineLearning #Collaboration #Innovation #RegenMed #PersonalizedMedicine #CellinoBio #YourCellsYourCure
-
-
🚀 We’re honored for our CEO & Co-Founder, Nabiha Saklayen to speak at #EmTech MIT Technology Review, happening from Sept. 30 - Oct. 1! Nabiha will join Reed Sturtevant, General Partner at Engine Ventures, in the session "Lessons Learned from Tough Tech" at 3:45 PM EDT on Day 1 (Sept. 30). They will explore how transformative “tough tech” can solve the world’s most pressing challenges by merging breakthrough #science, #engineering, and #leadership. Topics covered will include the ideation process that brings long-term tough tech projects to market in the most economical and efficient way possible. 🌟 Register to join us at MIT Campus in #Cambridge, MA, or online at https://bit.ly/3Tfzy6T Massachusetts Institute of Technology #RegenerativeMedicines #DeepTech #Biotech #Innovation #Biomanufacturing #AI #MachineLearning #PersonalizedMedicine #YourCellsYourCure #CellinoBio
-
-
🌟 We’re thrilled to introduce Lynette Tsai as Controller at Cellino! Lynette brings nearly 15 years of expertise in accounting and finance to our team. Her career began in public accounting at EY, followed by a role at WilliamsMarston, where she provided consulting and management services. She then served as Controller at Butlr Technologies and Berkshire Grey, specializing in IoT and AI-driven automation. We look forward to Lynette's contributions as she supports our work to advance personalized regenerative medicine at scale. Please join us in welcoming Lynette! 👏 #CellinoBio #Biotech #Innovation #STEMCareers #EmployeeSpotlight #RegenMed #PersonalizedMedicine #YourCellsYourCure #WelcomeToCellino
-
-
📢 We’re excited to welcome Owen Dray to Cellino as a Prototype Engineer! Owen recently graduated from Olin College with a degree in mechanical engineering. While at Olin, he was part of the Formula SAE team, designing and building an electric race car. He brings valuable experience from design and test engineering internships at Tesla, Blue Origin, and Formlabs. Join us in welcoming Owen as we work together to build scalable solutions for personalized regenerative medicines. 🚀 #CellinoBio #Biotech #Innovation #STEMCareers #EmployeeSpotlight #RegenMed #PersonalizedMedicine #YourCellsYourCure #WelcomeToCellino
-
-
🚀 We're excited for our Co-Founder & CEO Nabiha Saklayen to present at the "Big Data and AI in Biotech" event hosted by DANISH BIO - DANSK BIOTEK at Gorrissen Federspiel on October 2 in #Copenhagen! AI development is advancing at an incredible pace, and there are powerful applications within the biotechnology and personalized regenerative medicine fields. 🔹 Roald Forsberg of Raven biosciences and Martin S. Borchert of Novonesis will also be presenting, and Emma Jappe Lange of Biobridge Partners will lead a roundtable discussion on the state of AI in the Nordics. 🔹 Many thanks to Martin Dræbye Gantzhorn, Morten Engsbye, and Hans T. Schambye for the welcome. We look forward to seeing you there! 👉 For more details and registration details, visit https://lnkd.in/dfNSeAxR #AI #artificialintelligence #biotech #biomanufacturing #regenerativemedicine #bigdata
Are you ready to dive into the world of Big Data and AI in Biotech? DANISH BIO - DANSK BIOTEK and Gorrissen Federspiel invite you to an insightful afternoon where leading experts will explore the transformative impact of AI on the biotech industry. Martin Dræbye Gantzhorn, Morten Engsbye and Hans T. Schambye will welcome you, followed by a series of presentations from leading experts: ➡️ Roald Forsberg from Raven Bioscience ➡️ Martin S. Borchert from Novonesis ➡️ Nabiha Saklayen from Cellino Biotech After the presentations, we will host a roundtable discussion on the state of AI in the Nordics, moderated by Emma Jappe Lange from Biobridge Partners. Event Details: 🗓 2 October 2024 🕒 14:00-17:00 (Networking until 18:30) 📍 Axel Towers, Axeltorv 2, 1609 Copenhagen Don’t miss this opportunity to gain insights into how AI is shaping the future of biotech. Register now via the link: https://lnkd.in/dfNSeAxR We look forward to seeing you there.
-
🚨 Check out this informative blog from our Cellino Co-Founder & CTO Matthias Wagner! He explores why AI is central to the future of biotech, especially with applications in autonomous cell manufacturing and scaling to make therapies available for all humans. 📖 Read "AI: Scaling Therapies to More Humans" at https://lnkd.in/dkQMSUYN #AI #artificialintelligence #machinelearning #biotechnology #biomanufacturing #technology #iPSC #manufacturing #celltherapy
Yes, #AI will work in #biotech. In fact, it will be central to scaling novel therapies and giving access to hundreds of millions of patients. Why I am so excited about AI in #bioprocessing, specifically #celltherapy #manufacturing.
-
🚨 Reminder for Emory University Boston alums! Join us on Tuesday, September 10, from 6-8 PM EDT for the “TrailblazHER Talks Boston: Pathways to Leadership.” Hear from inspiring Emory women leaders, including Nabiha Saklayen, our CEO & Co-Founder, as they share their unique leadership paths and advice, moderated by Jacqueline Ganim-DeFalco 81C, Business Advisor and Founder of Marketing Recon. 🤝 Meet the panel: Nabiha Saklayen 12C, CEO and Co-Founder of Cellino Sophia Hall 09C, Deputy Litigation Director at Lawyers for Civil Rights Jodi Rosenbaum 97C, Founder and Chief Executive Officer of More Than Words Join us for an evening dedicated to learning, networking, and supporting the powerful initiatives of the Women of Emory Impact Circle Fund. We’re excited to connect and celebrate the impactful work of fellow alums! Emory Alumni Association Oxford College of Emory University #EmoryUniversity #CambridgeMA #GreaterBoston #WomenLeaders #Biotech #Innovation #Leadership #YourCellsYourCure #CellinoBio
-
-
📢 Biotech Week Boston is almost here! We’re looking forward to Marinna Madrid, PhD, our Co-Founder & Chief Product Officer, speaking at next month’s BioProcess International conference (#BPIconf) from September 24-26, 2024. 🗓 Save the date and be sure to attend these important sessions: 🔹 Tuesday, September 24, 11:45 AM - 12:15 PM EDT: Marinna will present on "An AI- and Laser-based Biomanufacturing Platform to Scale Production of Personalized Regenerative Cell Therapies." Join us to explore how Cellino’s innovative platform uses an #AI-driven optical bioprocess to enhance the scalability and consistency of autologous iPSC-derived therapy #biomanufacturing, addressing the challenges of current manual processes. 🔹 Thursday, September 26, 2:00 PM - 3:00 PM EDT: Marinna will join an exceptional panel of #biotech leaders to discuss "Adaptability of AI/ML for the BioPharma Industry," including William Whitford, Independent Consultant, and Christoph Herwig, Senior Scientific Advisor at Körber Pharma Austria GmbH. Moderator Amish Patel, Ph.D., Technical Operations at Calidi Biotherapeutics, will lead the discussion of how AI/ML is transforming biopharma, covering topics including AI/ML implementation strategies, cost reduction, accelerated timelines, and digitalization in manufacturing. 👉 For more details and the full agenda, visit https://lnkd.in/gDsiYiNn #BiotechWeekBoston #Biotech #BPI #Bioprocess #Innovation #ArtificialIntelligence #MachineLearning #PersonalizedMedicine #RegenMed #YourCellsYourCure #CellinoBio
-
👏 Thank you to everyone who joined us at Cambridge Healthtech Institute’s 16th Annual Bioprocessing Summit! We were pleased to have Michael C., Automation Engineer at Cellino, present insights on scaling #labautomation and advancing toward a more efficient, scalable future of #bioprocessing for patient-specific regenerative medicines. Our team looks forward to next year’s event! 🚀 #CHIBioprocessingSummit #AI #LabTechnology #Biotech #Innovation #RegenMed #Biomanufacturing #PersonalizedMedicine #CellinoBio
-